Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FSG59
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,968
Award facts
- Contract value 100% obligated
- $12,968.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,968.01 to AmerisourceBergen Drug Corp for 60-count tablets of Xifaxan 550 mg, an antibiotic medication used to treat traveler's diarrhea and certain gastrointestinal conditions. This competitively awarded, firm fixed-price delivery order was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As the prime contractor on the comprehensive DLA Troop Support Medical IDC, the company supplies a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems. This delivery order is part of AmerisourceBergen's extensive portfolio of competitively awarded federal contracts with DLA, demonstrating the company's capability to fulfill federal medical supply requirements across varying transaction values.
Quick answers
Who was awarded contract SPE2DB25FSG59?
SPE2DB25FSG59 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FSG59 worth?
The government has obligated $12,968 on SPE2DB25FSG59.
Is contract SPE2DB25FSG59 an order under another contract?
Yes. SPE2DB25FSG59 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FSG59 competed?
The extent of competition for SPE2DB25FSG59 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award